6 Result(s)
-
Article
Open AccessA case of lung adenocarcinoma harboring EGFR mutation and EML4-ALKfusion gene
Lung cancer is the leading cause of cancer-related death worldwide. Epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitor (TKI) is used for the patients with EGFR-mutant lung cancer. Recently, phase...
-
Article
Open AccessSepsis caused by Listeria monocytogenes during chemotherapy for small cell carcinoma of the thymus
Listeria monocytogenes is a facultative intracellular parasitic bacterium that is Gram positive, catalase positive, oxidase negative, and a facultative anaerobe. It is known to infect humans th...
-
Article
Open AccessDramatic response to alectinib in a patient of ALK-rearranged lung cancer with poor performance status
Lung cancers with anaplastic lymphoma kinase rearrangements are highly sensitive to anaplastic lymphoma kinase tyrosine kinase inhibition, underscoring the notion that such cancers are addicted to anaplastic l...
-
Article
Open AccessA single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
We aimed to evaluate the efficacy and safety of nab-paclitaxel in patients with refractory advanced non-small cell lung cancer who failed previous chemotherapy.
-
Article
Open AccessProcalcitonin expression in patients with large cell neuroendocrine carcinoma of the lung
Procalcitonin (PCT) has received much attention as a serum marker for bacterial infection. Elevated serum PCT is occasionally seen in severe trauma, heatstroke, and neoplastic diseases, including lung cancer w...
-
Article
Open AccessMorphological features of bronchiectasis in patients with non-tuberculous mycobacteriosis and interstitial pneumonia
To compare the morphological features of bronchiectasis between patients with different underlying diseases, we performed quantitative analysis of high-resolution computed tomography (HRCT) images of 14 patien...
